ReviewClinical pharmacology and therapeutics2021

Developing Drugs for Tissue-Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine.

Nathan D Seligson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.